UBS Group
INLX icon

UBS Group’s Intellinetics INLX Stock Holding History

UBS Group’s Portfolio INLX Stock Details INLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6 Sell
1
-265
-100% -$1.77K ﹤0.01% 10342
2026
Q1 		$1.98K Sell
266
-105
-28% -$819 ﹤0.01% 9389
2025
Q4 		$2.96K Sell
371
-3,226
-90% -$29.8K ﹤0.01% 9174
2025
Q3 		$40.6K Buy
3,597
+3,596
+359,600% +$42.1K ﹤0.01% 7709
2025
Q2 		$13 Hold
1
– – ﹤0.01% 10140
2025
Q1 		$12 Hold
1
– – ﹤0.01% 10112
2024
Q4 		$14 Hold
1
– – ﹤0.01% 9794
2024
Q3 		$11 Hold
1
– – ﹤0.01% 9350
2024
Q2 		$6 Buy
+1
New +$7 ﹤0.01% 9387
2024
Q1 		– Sell
-572
Closed -$2.89K – 9653
2023
Q4 		$2.89K Buy
+572
New +$2.53K ﹤0.01% 8040

Other funds holding INLX

BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

UBS Group's INLX Position: Q2 2026 in Review

UBS Group reduced its Intellinetics (INLX) stake by 100% in Q2 2026, selling an estimated $1.77K and leaving 1 share worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #10342.

UBS Group first reported a position in INLX in Q4 2023 and has held it in 10 quarters since. The position peaked at $40.6K in Q3 2025. 9 funds tracked by Wall St. Rank hold INLX as of Q2 2026.

  • UBS Group held 1 share of Intellinetics worth $6 as of Q2 2026.
  • UBS Group sold 265 Intellinetics shares in Q2 2026, an estimated $1.77K.
  • Intellinetics made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10342 holding.
  • UBS Group first reported a position in Intellinetics in Q4 2023 and has held it in 10 quarters since.
  • UBS Group's Intellinetics position peaked at $40.6K in Q3 2025.
  • 9 funds tracked by Wall St. Rank held Intellinetics as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.